{"id":"W4392203306","doi":"10.1016/j.xcrm.2024.101435","title":"Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial","year":2024,"lang":"en","type":"article","venue":"Cell Reports Medicine","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute of Cancer Research; Medical Research Council; Manchester Biomedical Research Centre; Ipsen; NIHR Cambridge Biomedical Research Centre; Rosetrees Trust; Royal Marsden NHS Foundation Trust; Department of Health and Social Care; Cancer Research UK; National Institute for Health and Care Research; National Institutes of Health; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Novartis; Melanoma Research Alliance; Francis Crick Institute; Wellcome Trust; Amgen","keywords":"Medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001028571,0.0005869496,0.001044964,0.0001726499,0.0001583811,0.0006147628,0.0003693794,0.0004554481,0.002015424],"category_scores_gemma":[0.0008376102,0.0001052876,0.0005314157,0.0002000978,0.0003277564,0.0005014378,0.0002783999,0.0009877862,0.0004417906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005656707,"about_ca_system_score_gemma":0.000490907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002939902,"about_ca_topic_score_gemma":0.001152814,"domain_scores_codex":[0.9996344,0.0002306416,0.00001504996,0.00003917544,0.00003760824,0.00004313369],"domain_scores_gemma":[0.9995722,0.00008001619,0.0000889645,0.00003129113,0.00004054822,0.0001869742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6039121,0.01276452,0.01378233,0.002655127,0.003100048,0.0005728424,0.000340905,0.00405631,0.03748877,0.0009353977,0.02360118,0.2967904],"study_design_scores_gemma":[0.5910363,0.3074302,0.04789846,0.0003845442,0.002257957,0.001975308,0.0002516595,0.007558708,0.0110928,0.001317506,0.02868556,0.0001109742],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809049,0.01136952,0.0004741792,0.00119004,0.0001795677,0.000479296,0.001422701,0.0001169169,0.003862736],"genre_scores_gemma":[0.9868079,0.004468122,0.0008819184,0.001008532,0.000198193,0.000669709,0.002905227,0.00003149206,0.003028869],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002015424,"threshold_uncertainty_score":0.006742239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05398573251415962,"score_gpt":0.3569114462957106,"score_spread":0.302925713781551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}